UNSPSC 51183801: Acarbose

This classification denotes a glucosidase inhibitor and anti-diabetic agent with the molecular formula C25H43NO18, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) T58MSI464G, chemically known as o-4,6-dideoxy-4-(((1s,4r,5s,6s)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-d-glucopyranosyl-(1->4)-o-alpha-d-glucopyranosyl-(1->4)-d-glucose but more generally known as acarbose, which bears US NIH Compound Identifier 41774.

UNSPSC 51183801 Acarbose is a Commodity-tier code covering the supply of this specific antidiabetic medication to state and local government health systems, correctional facilities, and social-service agencies. The scope of work encompasses manufacturer supply of acarbose in bulk or packaged form through authorized pharmaceutical wholesalers, meeting FDA compliance, current Good Manufacturing Practices (cGMP), and Drug Supply Chain Security Act (DSCSA) requirements. State and local buyers source acarbose as part of larger pharmaceutical procurement vehicles that bundle multiple generic medications and over-the-counter products under cooperative purchasing agreements, particularly through multistate consortia that aggregate demand across participating jurisdictions and facilities.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, has issued a Request for Proposal (solicitation S1070000015802, due March 26, 2026) to establish contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon. Under the MMCAP structure, vendors supply acarbose and related products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with contract pricing weighted heavily on price competitiveness (75 percent), fixed pricing stability (10 percent), EDI capability (5 percent), and administrative compliance (10 percent combined). Vendors must maintain relationships with at least two of the three wholesalers, carry commercial general liability insurance of $5,000,000 per occurrence and professional liability of $2,000,000, and accept a 3 percent administrative fee on all contract purchases. The resulting agreements are effective July 1, 2026, with a two-year initial term for new respondents and optional renewals at MMCAP's discretion.